Balyasny Asset Management’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,492,342
Closed -$6.31M 3263
2023
Q4
$6.31M Buy
2,492,342
+2,477,172
+16,329% +$5.77M 0.01% 1041
2023
Q3
$36.3K Buy
+15,170
New +$33.6K ﹤0.01% 2165
2022
Q4
Sell
-592,794
Closed -$1.72M 3354
2022
Q3
$1.72M Sell
592,794
-368,911
-38% -$1.55M 0.01% 1565
2022
Q2
$4.35M Buy
961,705
+882,393
+1,113% +$5.25M 0.01% 1001
2022
Q1
$636K Buy
79,312
+61,970
+357% +$547K ﹤0.01% 1754
2021
Q4
$202K Buy
+17,342
New +$208K ﹤0.01% 1851

Balyasny Asset Management's SLGC Position: Q1 2024 in Review

Balyasny Asset Management sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 2,492,342 shares — an estimated $6.31M sold.

Balyasny Asset Management first reported a position in SLGC in Q4 2021 and held it in 6 quarters. The position peaked at $6.31M in Q4 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Balyasny Asset Management reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 2,492,342 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $6.31M.
  • Balyasny Asset Management first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
  • Balyasny Asset Management's SomaLogic, Inc. Class A Common Stock position peaked at $6.31M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.